{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:36:17Z","timestamp":1791549377759,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["ICMR\/16\/1990\/SGP-2023"],"award-info":[{"award-number":["ICMR\/16\/1990\/SGP-2023"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"DOI":"10.1007\/s00204-026-04499-5","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T08:22:27Z","timestamp":1784535747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Revisiting cannabinoid receptor-2: a key regulator of hepatic steatosis, inflammatory cascades, and fibrotic progression"],"prefix":"10.1007","author":[{"given":"Shilpa","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswanath","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"4499_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/502542","author":"T Auguet","year":"2014","unstructured":"Auguet T et al (2014) Endocannabinoid receptors gene expression in morbidly obese women with nonalcoholic fatty liver disease. BioMed Res Int. https:\/\/doi.org\/10.1155\/2014\/502542","journal-title":"BioMed Res Int"},{"issue":"2","key":"4499_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.brainresbull.2004.12.002","volume":"65","author":"Y Avraham","year":"2005","unstructured":"Avraham Y et al (2005) Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice. Brain Res Bull 65(2):117\u2013123","journal-title":"Brain Res Bull"},{"issue":"8","key":"4499_CR3","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1096\/fj.06-7451com","volume":"21","author":"S B\u00e1tkai","year":"2007","unstructured":"B\u00e1tkai S et al (2007) Cannabinoid-2 receptor mediates protection against hepatic ischemia\/reperfusion injury. FASEB J: Off Publ Fed Am Soc Exp Biol 21(8):1788","journal-title":"FASEB J: Off Publ Fed Am Soc Exp Biol"},{"key":"4499_CR4","doi-asserted-by":"publisher","first-page":"106520","DOI":"10.1016\/j.prostaglandins.2020.106520","volume":"152","author":"T Behl","year":"2021","unstructured":"Behl T et al (2021) Understanding the possible role of endocannabinoid system in obesity. Prostaglandins Other Lipid mediat 152:106520","journal-title":"Prostaglandins Other Lipid mediat"},{"issue":"1\u20133","key":"4499_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ejphar.2007.02.066","volume":"565","author":"FJ Bermudez-Silva","year":"2007","unstructured":"Bermudez-Silva FJ et al (2007) Role of cannabinoid CB2 receptors in glucose homeostasis in rats. Eur J Pharmacol 565(1\u20133):207\u2013211","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"4499_CR6","doi-asserted-by":"publisher","first-page":"5175","DOI":"10.1172\/JCI76388","volume":"124","author":"DG Cotter","year":"2014","unstructured":"Cotter DG et al (2014) Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia. J Clin Investig 124(12):5175\u20135190","journal-title":"J Clin Investig"},{"key":"4499_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ijid.2017.03.008","volume":"59","author":"E Dai","year":"2017","unstructured":"Dai E et al (2017) Hepatic expression of cannabinoid receptors CB1 and CB2 correlate with fibrogenesis in patients with chronic hepatitis B. Int J Infect Dis 59:124\u2013130","journal-title":"Int J Infect Dis"},{"issue":"1","key":"4499_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/srep28806","volume":"6","author":"T Dena\u00ebs","year":"2016","unstructured":"Dena\u00ebs T et al (2016) The cannabinoid receptor 2 protects against alcoholic liver disease via a macrophage autophagy-dependent pathway. Sci Rep 6(1):28806","journal-title":"Sci Rep"},{"issue":"6","key":"4499_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005844","volume":"4","author":"V Deveaux","year":"2009","unstructured":"Deveaux V, Cadoudal T, Ichigotani Y, Teixeira-Clerc F, Louvet A, Manin S, Nhieu J-V et al (2009a) Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis. PLoS One 4(6):e5844","journal-title":"PLoS One"},{"key":"4499_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-230X-14-131","volume":"14","author":"L Flores-Contreras","year":"2014","unstructured":"Flores-Contreras L et al (2014) Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C. BMC Gastroenterol 14:1\u201311","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"4499_CR11","first-page":"263846","volume":"2013","author":"RA Fraga-Silva","year":"2013","unstructured":"Fraga-Silva RA et al (2013) Treatment with CB2 agonist JWH-133 reduces histological features associated with erectile dysfunction in hypercholesterolemic mice. J Immunol Res 2013(1):263846","journal-title":"J Immunol Res"},{"issue":"5","key":"4499_CR12","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.cell.2018.09.053","volume":"175","author":"M Grohmann","year":"2018","unstructured":"Grohmann M et al (2018) Obesity drives STAT-1-dependent NASH and STAT-3-dependent HCC. Cell 175(5):1289\u20131306","journal-title":"Cell"},{"issue":"3","key":"4499_CR13","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1053\/j.gastro.2004.12.050","volume":"128","author":"B Julien","year":"2005","unstructured":"Julien B et al (2005) Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology 128(3):742\u2013755. https:\/\/doi.org\/10.1053\/j.gastro.2004.12.050","journal-title":"Gastroenterology"},{"key":"4499_CR14","doi-asserted-by":"crossref","unstructured":"Kalkan H, Flamand N (2025) The CB\u2082 receptor in immune regulation and disease: genetic architecture, epigenetic control, and emerging therapeutic strategies","DOI":"10.20944\/preprints202507.0638.v1"},{"issue":"10","key":"4499_CR15","doi-asserted-by":"publisher","first-page":"8332","DOI":"10.1007\/s12035-016-0313-5","volume":"54","author":"M Kruk-Slomka","year":"2017","unstructured":"Kruk-Slomka M et al (2017) Endocannabinoid system: the direct and indirect involvement in the memory and learning processes\u2014a short review. Mol Neurobiol 54(10):8332\u20138347. https:\/\/doi.org\/10.1007\/s12035-016-0313-5","journal-title":"Mol Neurobiol"},{"issue":"4","key":"4499_CR16","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1097-2765(00)80210-5","volume":"4","author":"N Kubota","year":"1999","unstructured":"Kubota N et al (1999) PPAR\u03b3 mediates high-fat diet\u2013induced adipocyte hypertrophy and insulin resistance. Mol Cell 4(4):597\u2013609","journal-title":"Mol Cell"},{"key":"4499_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.616813","volume":"11","author":"C-Y Liu","year":"2021","unstructured":"Liu C-Y et al (2021) Ampk\/Sirt1 pathway is involved in arctigenin-mediated protective effects against myocardial ischemia-reperfusion injury. Front Pharmacol 11:2351","journal-title":"Front Pharmacol"},{"key":"4499_CR18","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.931236","volume":"27","author":"C Long","year":"2021","unstructured":"Long C et al (2021) Knockout of the cannabinoid receptor 2 gene promotes inflammation and hepatic stellate cell activation by promoting A20\/nuclear factor-\u03baB (NF-\u03baB) expression in mice with carbon tetrachloride-induced liver fibrosis. Med Sci Monit 27:e931236-1","journal-title":"Med Sci Monit"},{"issue":"2","key":"4499_CR19","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/sj.bjp.0707511","volume":"153","author":"S Lotersztajn","year":"2008","unstructured":"Lotersztajn S et al (2008) CB2 receptors as new therapeutic targets for liver diseases. Br J Pharmacol 153(2):286\u2013289","journal-title":"Br J Pharmacol"},{"key":"4499_CR41","doi-asserted-by":"crossref","unstructured":"Louvet A et al (2011) Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice. Hepatology 54(4):1217\u20131226","DOI":"10.1002\/hep.24524"},{"issue":"SUPPL. 1","key":"4499_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2826.2008.01671.x","volume":"20","author":"K Mackie","year":"2008","unstructured":"Mackie K (2008) Cannabinoid receptors: where they are and what they do. J Neuroendocrinol 20(SUPPL. 1):10\u201314. https:\/\/doi.org\/10.1111\/j.1365-2826.2008.01671.x","journal-title":"J Neuroendocrinol"},{"key":"4499_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ejphar.2014.08.021","volume":"742","author":"MF Mahmoud","year":"2014","unstructured":"Mahmoud MF et al (2014) Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats. Eur J Pharmacol 742:118\u2013124. https:\/\/doi.org\/10.1016\/j.ejphar.2014.08.021","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"4499_CR22","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3889\/oamjms.2019.194","volume":"7","author":"HM Mahmoud","year":"2019","unstructured":"Mahmoud HM et al (2019) AM-1241 CB2 receptor agonist attenuates inflammation, apoptosis and stimulate progenitor cells in bile duct ligated rats. Open Access Macedonian J Med Sci 7(6):925","journal-title":"Open Access Macedonian J Med Sci"},{"issue":"12","key":"4499_CR23","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.3390\/ph14121316","volume":"14","author":"J Matheson","year":"2021","unstructured":"Matheson J et al (2021) Potential of fatty acid amide hydrolase (FAAH), monoacylglycerol lipase (MAGL), and diacylglycerol lipase (DAGL) enzymes as targets for obesity treatment: a narrative review. Pharmaceuticals 14(12):1316","journal-title":"Pharmaceuticals"},{"issue":"9","key":"4499_CR24","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/obr.12862","volume":"20","author":"RCR Meex","year":"2019","unstructured":"Meex RCR, Blaak EE, van Loon LJC (2019) Lipotoxicity plays a key role in the development of both insulin resistance and muscle atrophy in patients with type 2 diabetes. Obes Rev 20(9):1205\u20131217","journal-title":"Obes Rev"},{"issue":"2","key":"4499_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1478-3231.2006.01401.x","volume":"27","author":"N Mendez-Sanchez","year":"2007","unstructured":"Mendez-Sanchez N et al (2007) Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease. Liver Int 27(2):215\u2013219. https:\/\/doi.org\/10.1111\/j.1478-3231.2006.01401.x","journal-title":"Liver Int"},{"issue":"3","key":"4499_CR26","doi-asserted-by":"publisher","first-page":"H1145","DOI":"10.1152\/ajpheart.01328.2007","volume":"294","author":"F Montecucco","year":"2008","unstructured":"Montecucco F et al (2008) CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways. Am J Physiol Heart Circ Physiol 294(3):H1145\u2013H1155","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"4499_CR27","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1124\/jpet.107.131896","volume":"324","author":"J Mu\u00f1oz-Luque","year":"2008","unstructured":"Mu\u00f1oz-Luque J et al (2008) Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats. J Pharmacol Exp Ther 324(2):475\u2013483","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"4499_CR28","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1002\/oby.20358","volume":"21","author":"AR Nascimento","year":"2013","unstructured":"Nascimento AR et al (2013) Structural and functional microvascular alterations in a rat model of metabolic syndrome induced by a high-fat diet. Obesity 21(10):2046\u20132054","journal-title":"Obesity"},{"key":"4499_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087601","author":"L O\u2019Keefe","year":"2023","unstructured":"O\u2019Keefe L et al (2023) Treatment of diet-induced obese rats with CB2 agonist AM1241 or CB2 antagonist AM630 reduces leptin and alters thermogenic mRNA in adipose tissue. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24087601","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4499_CR30","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1172\/JCI200523057","volume":"115","author":"D Osei-Hyiaman","year":"2005","unstructured":"Osei-Hyiaman D et al (2005) Endocannabinoid activation at hepatic CB 1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Investig 115(5):1298\u20131305","journal-title":"J Clin Investig"},{"issue":"1","key":"4499_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.neuint.2007.06.033","volume":"52","author":"E P\u00e1ldyov\u00e1","year":"2008","unstructured":"P\u00e1ldyov\u00e1 E et al (2008) Noladin ether, a putative endocannabinoid, inhibits \u00b5-opioid receptor activation via CB2 cannabinoid receptors. Neurochem Int 52(1):321\u2013328. https:\/\/doi.org\/10.1016\/j.neuint.2007.06.033","journal-title":"Neurochem Int"},{"key":"4499_CR32","doi-asserted-by":"publisher","unstructured":"Ratano P et al (2018) Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation, Neuropharmacology. Elsevier Ltd. Available at: https:\/\/doi.org\/10.1016\/j.neuropharm.2018.05.030","DOI":"10.1016\/j.neuropharm.2018.05.030"},{"key":"4499_CR33","doi-asserted-by":"crossref","unstructured":"Rossi F et al (2012) \u2018Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease\u2019","DOI":"10.1371\/journal.pone.0042259"},{"issue":"10","key":"4499_CR34","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1136\/gutjnl-2015-310212","volume":"65","author":"K-T Suk","year":"2016","unstructured":"Suk K-T et al (2016) Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis. Gut 65(10):1721\u20131732","journal-title":"Gut"},{"issue":"3","key":"4499_CR35","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/hep.23779","volume":"52","author":"F Teixeira-Clerc","year":"2010","unstructured":"Teixeira-Clerc F et al (2010) Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration. Hepatology 52(3):1046\u20131059. https:\/\/doi.org\/10.1002\/hep.23779","journal-title":"Hepatology"},{"issue":"3","key":"4499_CR36","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1007\/s13277-015-4182-8","volume":"37","author":"S Theocharis","year":"2016","unstructured":"Theocharis S et al (2016) Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients\u2019 survival. Tumor Biology 37(3):3647\u20133656","journal-title":"Tumor Biol"},{"issue":"11","key":"4499_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140592","volume":"10","author":"ANA Verty","year":"2015","unstructured":"Verty ANA et al (2015) Anti-obesity effect of the CB2 receptor agonist JWH-015 in diet-induced obese mice. PLoS One 10(11):e0140592","journal-title":"PLoS One"},{"issue":"10","key":"4499_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jfbc.13371","volume":"44","author":"SK Wong","year":"2020","unstructured":"Wong SK et al (2020) Biochemical and histopathological assessment of liver in a rat model of metabolic syndrome induced by high-carbohydrate high-fat diet. J Food Biochem 44(10):1\u20139. https:\/\/doi.org\/10.1111\/jfbc.13371","journal-title":"J Food Biochem"},{"issue":"1","key":"4499_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cancergencyto.2006.06.014","volume":"171","author":"X Xu","year":"2006","unstructured":"Xu X et al (2006) Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma. Cancer Genet Cytogenet 171(1):31\u201338","journal-title":"Cancer Genet Cytogenet"},{"issue":"5","key":"4499_CR40","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.jhep.2014.05.049","volume":"61","author":"Y-Y Yang","year":"2014","unstructured":"Yang Y-Y et al (2014) Long-term cannabinoid type 2 receptor agonist therapy decreases bacterial translocation in rats with cirrhosis and ascites. J Hepatol 61(5):1004\u20131013","journal-title":"J Hepatol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04499-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-026-04499-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04499-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T08:22:30Z","timestamp":1784535750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-026-04499-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":41,"alternative-id":["4499"],"URL":"https:\/\/doi.org\/10.1007\/s00204-026-04499-5","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"24 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This article is a review of previously published studies and does not contain any new studies involving human participants or animals performed by the authors. Therefore, ethical approval and informed consent were not required. The authors have complied with the ethical standards of the Journal of Endocrinological Investigation.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}